跳至主要内容
临床试验/NCT05106049
NCT05106049Unknown不适用

Early Detection of Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease by Measuring Serum Adiponectin Level.

Assiut University0 个研究点目标入组 90 人开始时间: 2021年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
主要终点
Correlate serum Adiponectin level with renal impairment in non-alcoholic fatty liver disease.

研究概览

简要总结

Early detection of renal impairment in patients with non-alcoholic fatty liver disease and its correlation with serum Adiponectin level.

详细描述

Detection of serum Adiponectin by ELISA technique using (EIA-3418) KIT, DRG international inc., USA

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with fatty liver aged from 18 to 60 yrs either diabetic or not .
  • Patient with normal echogenic kidney in ultrasound and eGFR more than 60 mL/min/1.73m
  • The Control group are completely healthy subjects without any systemic or liver and kidney affection

排除标准

  • Patients less than 18 yrs & more than 60 yrs .
  • All patients having any other causes of renal and hepatic disease rather than Diabetes and having any other systemic problem.

结局指标

主要结局

Correlate serum Adiponectin level with renal impairment in non-alcoholic fatty liver disease.

时间窗: baseline

measure level of serum Adiponectin in non-alcoholic fatty liver patients to detect early renal impairment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hend Abdelrheem Ahmed

Hend Abdelrheem

Assiut University

相似试验